Columbus
[caption id align="alignnone" width="2000"] Photo: Drive Capital [/caption] Columbus-based Drive Capital has announced a strategic investment of at least $750 million in future fund commitments while also selling a minority stake in its management company. Drive says the commitment by Collective Global and Collective
Columbus
[caption id align="alignnone" width="2491"] 2023 DataConnect [/caption] In just eight years, Women in Analytics has gone from an Ohio State University student’s idea to a national organization supporting a community of about 8,000 data enthusiasts. And its flagship DataConnect conference, held annually
Columbus
[caption id align="alignnone" width="1302"] Image: Nationwide Children’s Hospital [/caption] This article orginally appeared on Purpose.Jobs. With a string of major fundraising announcements, product developments, and new facility debuts, Columbus is shaping into a force in the biotechnology space. In fact, it’s
Columbus
Redi Health, a Columbus-based provider of digital pharma support to patients with chronic health conditions, has raised $14 million in a Series B round. Redi says the funding underscores its success in reaching millions of patients across the country and will be used to solidify its position as a leader
Columbus
[caption id align="alignnone" width="3786"] Photo: Ohio State [/caption] The Ohio State University’s annual research and development expenditures reached an all-time record of $1.449 billion last year, the university disclosed in its annual report of resources available to perform cutting-edge science and creative
Columbus
A clean energy company spun off from Ohio State and backed by Bill Gates has raised $246 million. Koloma, based in Denver but with a lab in Columbus, has developed technology to extract carbon-free hydrogen from underground deposits. The company licenses technology from Ohio State, where CTO Tom Darrah is
Columbus
Basking Biosciences, a company developing a novel therapy to treat stroke, raised $55 million from a group of investors including The Ohio State University. The clinical-stage biopharmaceutical company will use the proceeds to accelerate clinical development. Last year, Basking announced positive Phase 1 results for the BB-031. ARCH Venture Partners
Columbus
[caption id align="alignnone" width="1302"] Image: Nationwide Children’s Hospital [/caption] Several of Ohio’s biggest names in healthcare are teaming up for a first-of-its-kind partnership to produce and commercialize pediatric medical devices. With support from a $6.95 million grant from the Food and
Columbus
Clarametyx Biosciences, a Columbus-based BioTech startup, has raised a $33 million Series A round to advance its cutting-edge anti-biofilm biologics for combating serious bacterial infections. The company, founded in 2020, specializes in developing targeted, immune-empowering biologic therapies to address persistent infections linked to biofilms. Also announced was a partnership with
Columbus
[caption id align="alignnone" width="1280"] Image: Pathfinder Product [/caption] How ‘2 Degrees of Kevin Bacon’ Led to Columbus Acquisition Columbus-based software consultancy Test Double has acquired product consultancy Pathfinder Product thanks to complementary services, a shared vision, and two degrees of Kevin Bacon. Test Double
Infrastructure
In the mid-to-late 90s, the U.S. enjoyed times of peace and security. But then the Columbine School Shooting happened in 1999 and September 11th followed just a couple years later. Inspired by these events, Mike MacLeod founded Status Solutions in Columbus, aiming to improve situational awareness, especially in schools.
Columbus
[caption id align="alignnone" width="3000"] Image: Forge Biologics [/caption] Forge Biologics, a Columbus-based gene therapy development startup, announced today they're to be acquired by Japanese Ajinomoto Co., Inc. for $620 million. Forge was founded in 2020 by Timothy J. Miller, Ph.D. (CEO